- Home
- MMA vs XLO Comparison
MMA vs XLO Comparison
Compare MMA & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MMA
- XLO
- Stock Information
- Founded
- MMA 2013
- XLO 2016
- Country
- MMA Australia
- XLO United States
- Employees
- MMA N/A
- XLO N/A
- Industry
- MMA
- XLO Biotechnology: Pharmaceutical Preparations
- Sector
- MMA
- XLO Health Care
- Exchange
- MMA Nasdaq
- XLO Nasdaq
- Market Cap
- MMA 11.1M
- XLO 35.7M
- IPO Year
- MMA 2024
- XLO 2021
- Fundamental
- Price
- MMA $1.82
- XLO $0.75
- Analyst Decision
- MMA
- XLO Buy
- Analyst Count
- MMA 0
- XLO 2
- Target Price
- MMA N/A
- XLO $3.00
- AVG Volume (30 Days)
- MMA 11.2M
- XLO 946.5K
- Earning Date
- MMA 01-01-0001
- XLO 11-06-2025
- Dividend Yield
- MMA N/A
- XLO N/A
- EPS Growth
- MMA N/A
- XLO N/A
- EPS
- MMA N/A
- XLO N/A
- Revenue
- MMA $407,412.00
- XLO $15,001,000.00
- Revenue This Year
- MMA N/A
- XLO $982.12
- Revenue Next Year
- MMA N/A
- XLO N/A
- P/E Ratio
- MMA N/A
- XLO N/A
- Revenue Growth
- MMA N/A
- XLO 536.45
- 52 Week Low
- MMA $0.60
- XLO $0.62
- 52 Week High
- MMA $4.11
- XLO $1.70
- Technical
- Relative Strength Index (RSI)
- MMA 75.30
- XLO 60.31
- Support Level
- MMA $1.59
- XLO $0.71
- Resistance Level
- MMA $2.00
- XLO $0.78
- Average True Range (ATR)
- MMA 0.29
- XLO 0.04
- MACD
- MMA 0.10
- XLO 0.01
- Stochastic Oscillator
- MMA 44.91
- XLO 64.03
About MMA Alta Global Group Limited
Mixed Martial Arts Group Ltd formerly Alta Global Group Ltd is a technology company engaged in the provision and administration of mixed martial arts training programs, and gym programs. It provides subscription-based products and services, offering both B2B SaaS solutions and B2C products and programs, covering online engagement, online content, and immersive in-gym experiences. The company's business units are; Trainalta.com; Mixed Martial Arts.com; and Hype.Co, Mobile Marketing solution. Its Alta Platform serves as a comprehensive solution for martial arts and combat sports, offering a blend of four core products: the Warrior Training Program, UFC Fight Fit Program, Alta Academy, and the Alta Community.
About XLO Xilio Therapeutics Inc.
Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies (including bispecifics) and immune cell engagers (including tumor-activated cell engagers and tumor-activated effector-enhanced cell engagers).